Gene editing company CRISPR Therapeutics AG (NASDAQ:CRSP) hired Steve Caffé as head of regulatory affairs. Caffé was SVP at Ra Pharmaceuticals Inc. (NASDAQ:RARX).
mRNA company Moderna Therapeutics Inc. (Cambridge, Mass.) hired Megan Pace as chief
This article may not be distributed to non-subscribersPURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD